Hossam Shaltout to Drug Design
This is a "connection" page, showing publications Hossam Shaltout has written about Drug Design.
Connection Strength
0.195
-
Elzahhar PA, Elkazaz S, Soliman R, El-Tombary AA, Shaltout HA, El-Ashmawy IM, Abdel Wahab AE, El-Hawash SA. Design and synthesis of some new 2,3'-bipyridine-5-carbonitriles as potential anti-inflammatory/antimicrobial agents. Future Med Chem. 2017 08; 9(12):1413-1450.
Score: 0.153
-
AlFadly ED, Elzahhar PA, Tramarin A, Elkazaz S, Shaltout H, Abu-Serie MM, Janockova J, Soukup O, Ghareeb DA, El-Yazbi AF, Rafeh RW, Bakkar NZ, Kobeissy F, Iriepa I, Moraleda I, Saudi MNS, Bartolini M, Belal ASF. Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase. Eur J Med Chem. 2019 Apr 01; 167:161-186.
Score: 0.042